MedPath

Interventions for Moderate Malnutrition in Pregnancy

Not Applicable
Completed
Conditions
Moderate Malnutrition
Pregnancy
Interventions
Dietary Supplement: corn-soy blend
Dietary Supplement: ready-to-use supplementary food
Dietary Supplement: UNIMMAP
Dietary Supplement: iron
Dietary Supplement: folic acid
Registration Number
NCT02120599
Lead Sponsor
Washington University School of Medicine
Brief Summary

Malnutrition during pregnancy is more common in poor women in the developing world due to inadequate dietary intake combined with increased nutrient requirements; pregnancy risk is more consequential than among other demographic groups with increased risk of maternal and infant mortality and the lifelong effects of fetal malnutrition. The benefits of treating moderate malnutrition during pregnancy remain largely undocumented. This study tests the hypothesis that providing either a fortified flour or fortified paste-based supplementary food designed to replete the nutrient deficits during pregnancy will result in improved maternal nutritional recovery rates and higher infant birth weights and lengths. This study is a randomized, controlled clinical trial of 3 supplementary foods in 1800 moderately malnourished Malawian women who are pregnant. Subjects will receive one of 3 food rations: 1) a ready-to-use supplementary food formulated to deliver about 200% of the recommended daily allowance (RDA) of most micronutrients in pregnancy (RUSF-P), 2) corn soy blend with a multiple micronutrient tablet chosen to deliver about 200% of the RDA of most micronutrients (CSB-P) or 3), the standard of care which is a corn soy blend with supplementary iron and folic acid (CSB), delivering between 0-350% of the RDA. Subjects will receive the supplementary food until they recover from MAM. The outcome of the pregnancy and maternal nutritional status will be followed until 3 months after delivery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
1867
Inclusion Criteria
  • Pregnant and consenting to study participation and HIV testing (if not already performed)
  • mid-upper-arm circumference (MUAC) ≤ 23 cm
  • planning to stay in the area and attend the clinic during pregnancy and for 3 months post partum
Read More
Exclusion Criteria
  • Pregnancy complications such as gestational diabetes, pre-eclampsia, hypertension
  • Severe anemia (Hg <7.0 mg/dl)
  • Severe malnutrition
  • under 18 years of age
  • over estimated 35 weeks of gestation
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
corn-soy-blend + multiple micronutrientscorn-soy blendThe treatment provided to women randomized to this arm of the study includes 200gm/d CSB along with a standard maternal multiple micronutrient tablet, which together provide a comparable amount of energy, protein and micronutrients to the ready-to-use supplemental food. The micronutrient supplement known as the United Nations Children's Emergency Fund (UNICEF) / World Health Organization (WHO) / United Nations University (UNU) international multiple micronutrient preparation (UNIMMAP) is widely available and has been used in many settings worldwide in pregnant women.
ready-to-use supplementary foodready-to-use supplementary foodRUSF-P (ready-to-use supplementary food) provides 750 kcal/d, 20 g protein/d, and 200% of RDA/d for most micronutrients during pregnancy (except for vitamins A, B3, folic acid, minerals iodine, magnesium, and calcium which will remain near 100%)
corn-soy-blend + multiple micronutrientsUNIMMAPThe treatment provided to women randomized to this arm of the study includes 200gm/d CSB along with a standard maternal multiple micronutrient tablet, which together provide a comparable amount of energy, protein and micronutrients to the ready-to-use supplemental food. The micronutrient supplement known as the United Nations Children's Emergency Fund (UNICEF) / World Health Organization (WHO) / United Nations University (UNU) international multiple micronutrient preparation (UNIMMAP) is widely available and has been used in many settings worldwide in pregnant women.
corn-soy-blendcorn-soy blendThis is the control group for the study, which will receive the Malawi standard of care. The treatment provided to women randomized to this arm of the study includes daily iron (60 mg) and folic acid (400 mcg) supplementation, along with 4 kg/2 weeks corn-soy blend (\~357 gm/d CSB).
corn-soy-blendfolic acidThis is the control group for the study, which will receive the Malawi standard of care. The treatment provided to women randomized to this arm of the study includes daily iron (60 mg) and folic acid (400 mcg) supplementation, along with 4 kg/2 weeks corn-soy blend (\~357 gm/d CSB).
corn-soy-blendironThis is the control group for the study, which will receive the Malawi standard of care. The treatment provided to women randomized to this arm of the study includes daily iron (60 mg) and folic acid (400 mcg) supplementation, along with 4 kg/2 weeks corn-soy blend (\~357 gm/d CSB).
Primary Outcome Measures
NameTimeMethod
Maternal change in mid-upper arm circumference (MUAC)up to 40 weeks

average change in mid-upper-arm circumference

infant birth weightup to 40 weeks

mean birth weights of infants born to mothers in the study

Proportion recovered from moderate acute malnutrition (MAM)up to 40 weeks

proportion of women who reach mid-upper arm circumference (MUAC) \> 23.5 cm for 2 consecutive visits

premature deliveryup to 36 weeks

proportion of infants born prematurely

infant birth lengthup to 40 weeks

mean birth length of infants born to women in the study

Secondary Outcome Measures
NameTimeMethod
pregnancy complicationsup to 40 weeks

rate of pregnancy complications

maternal weight gainup to 40 weeks
infant length at 3 months3 months
maternal hemoglobin8 weeks

changes in average hemoglobin level

infant survival at 3 months3 months
infant weight at 3 months3 months

Trial Locations

Locations (2)

Blantyre District

🇲🇼

Blantyre, Malawi

Chikwawa District

🇲🇼

Chikwawa, Malawi

© Copyright 2025. All Rights Reserved by MedPath